Examination Report |
1 | Power of Attorney | 23 Dec 2010 |
1 | TM-1 | 23 Dec 2010 |
10 | Journal Copy | 31 Oct 2012 |
11 | TM-R(RENEWAL OF TRADE MARK) | 17 Sep 2021 |
12 | Note Sheet | 10 Mar 2022 |
13 | Renewal Certificate | 11 Mar 2022 |
2 | Power of Attorney | 23 Dec 2010 |
2 | TM-1 | 23 Dec 2010 |
3 | Additional Representation Sheet | 23 Dec 2010 |
4 | TM-16 | 02 Feb 2012 |
5 | Power of Attorney | 02 Feb 2012 |
6 | Correspondence | 22 Feb 2012 |
7 | Correspondence | 21 Mar 2012 |
8 | Correspondence | 30 Mar 2012 |
9 | Correspondence | 04 May 2012 |
1 | O3 NOTICE | 10732558 | 5028136 | 26 Nov 2020 |
2 | RENEWAL NOTICE | 13171521 | 11 Mar 2022 |
Trademark was applied on 23 December 2010 with IP India.
Proprietor of Mitotax 250mg injection is DR.REDDYS LABORATORIES.
Class(es) in which the trademark was applied to is 5.
Status of Mitotax 250mg injection is Registered.
Application number alloted to the trademark is 2073571.
Aditya & Associates is the Trademark agent/attorney.
Trademark has been filed in the following category:
WORD